Karen L. Parkhill's most recent trade in HP Inc was a trade of 130,826 Restricted Stock Units done . Disclosure was reported to the exchange on Dec. 8, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| HP Inc. | Karen L. Parkhill | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 130,826 | 130,826 | - | - | Restricted Stock Units | |
| HP Inc. | Karen L. Parkhill | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2025 | 28,570 | 114,806 (0%) | 0% | 0 | Common Stock | |
| HP Inc. | Karen L. Parkhill | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2025 | 28,570 | 54,870 | - | - | Restricted Stock Units | |
| HP Inc. | Karen L. Parkhill | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.91 per share. | 07 Dec 2025 | 12,672 | 102,134 (0%) | 0% | 25.9 | 328,332 | Common Stock |
| HP Inc. | Karen L. Parkhill | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2025 | 158,523 | 305,344 | - | - | Restricted Stock Units | |
| HP Inc. | Karen L. Parkhill | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2025 | 158,523 | 158,523 (0%) | 0% | 0 | Common Stock | |
| HP Inc. | Karen L. Parkhill | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.05 per share. | 05 Aug 2025 | 72,287 | 86,236 (0%) | 0% | 25.0 | 1,810,789 | Common Stock |
| AMEX | Karen L. Parkhill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2025 | 948 | 8,431 | - | - | Share Equivalent Units | |
| HP Inc. | Karen L. Parkhill | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 82,305 | 82,305 | - | - | Restricted Stock Units | |
| HP Inc. | Karen L. Parkhill | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2024 | 458,015 | 458,015 | - | - | Restricted Stock Units | |
| Medtronic | Karen L. Parkhill | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2024 | 7,132 | 0 | - | - | Performance Share Units | |
| Medtronic | Karen L. Parkhill | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2024 | 7,132 | 53,459 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic | Karen L. Parkhill | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.51 per share. | 02 Aug 2024 | 3,581 | 46,730 (0%) | 0% | 81.5 | 291,887 | Ordinary Shares |
| Medtronic | Karen L. Parkhill | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.51 per share. | 02 Aug 2024 | 3,148 | 50,311 (0%) | 0% | 81.5 | 256,593 | Ordinary Shares |
| AMEX | Karen L. Parkhill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2024 | 955 | 7,306 | - | - | Share Equivalent Units | |
| Medtronic | Karen L. Parkhill | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2023 | 7,105 | 52,246 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic | Karen L. Parkhill | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2023 | 7,105 | 0 | - | - | Performance Share Units | |
| Medtronic | Karen L. Parkhill | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.49 per share. | 03 Aug 2023 | 5,919 | 46,327 (0%) | 0% | 84.5 | 500,096 | Ordinary Shares |
| Medtronic | Karen L. Parkhill | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2023 | 88,254 | 88,254 | - | - | Stock Option (Right to Buy) | |
| Medtronic | Karen L. Parkhill | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2023 | 31,336 | 31,336 | - | - | Performance Share Units | |
| Medtronic | Karen L. Parkhill | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2023 | 12,535 | 44,418 (0%) | 0% | 0 | Ordinary Shares | |
| AMEX | Karen L. Parkhill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 1,364 | 6,351 | - | - | Share Equivalent Units | |
| Medtronic | Karen L. Parkhill | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 84,905 | 84,905 | - | - | Stock Option (Right to Buy) | |
| Medtronic | Karen L. Parkhill | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 26,859 | 26,859 | - | - | Performance Share Units | |
| Medtronic | Karen L. Parkhill | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 10,744 | 30,962 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic | Karen L. Parkhill | EVP & Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Jul 2022 | 15,151 | 20,218 (0%) | 0% | 0 | Ordinary Shares | |
| AMEX | Karen L. Parkhill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 1,218 | 4,909 | - | - | Share Equivalent Units | |
| Medtronic | Karen L. Parkhill | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 110.00 per share. | 18 Mar 2022 | 682 | 34,946 (0%) | 0% | 110 | 75,020 | Ordinary Shares |
| Medtronic | Karen L. Parkhill | EVP & Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Dec 2021 | 49,859 | 0 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic | Karen L. Parkhill | EVP & Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Dec 2021 | 49,859 | 49,859 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic | Karen L. Parkhill | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 110.00 per share. | 06 Dec 2021 | 682 | 35,446 (0%) | 0% | 110 | 75,020 | Ordinary Shares |
| Medtronic | Karen L. Parkhill | EVP & Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Oct 2021 | 37,859 | 37,859 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic | Karen L. Parkhill | EVP & Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Oct 2021 | 37,859 | 47,974 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic | Karen L. Parkhill | EVP & Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Oct 2021 | 12,000 | 49,859 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic | Karen L. Parkhill | EVP & Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Oct 2021 | 12,000 | 35,974 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic | Karen L. Parkhill | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 61,187 | 61,187 | - | - | Stock Option (Right to Buy) | |
| Medtronic | Karen L. Parkhill | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 17,904 | 17,904 | - | - | Performance Share Units | |
| Medtronic | Karen L. Parkhill | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 7,162 | 85,833 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic | Karen L. Parkhill | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.31 per share. | 02 Aug 2021 | 6,839 | 78,671 (0%) | 0% | 131.3 | 898,029 | Ordinary Shares |
| Medtronic | Karen L. Parkhill | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 1,085 | 1,085 | - | - | Stock Option (Right to Buy) | |
| Medtronic | Karen L. Parkhill | EVP & Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Jun 2021 | 238 | 843 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic | Karen L. Parkhill | EVP & Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Jun 2021 | 238 | 85,747 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic | Karen L. Parkhill | EVP & Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Jun 2021 | 238 | 843 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic | Karen L. Parkhill | EVP & Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Jun 2021 | 238 | 843 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic | Karen L. Parkhill | EVP & Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Jun 2021 | 238 | 85,985 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic | Karen L. Parkhill | EVP & Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Jun 2021 | 238 | 85,509 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic | Karen L. Parkhill | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 124.47 per share. | 15 Jun 2021 | 605 | 86,223 (0%) | 0% | 124.5 | 75,304 | Ordinary Shares |